Annual CFI
-$2800.00
-$2800.00-100.00%
31 December 2023
Summary:
Processa Pharmaceuticals annual cash flow from investing activities is currently -$2800.00, with the most recent change of -$2800.00 (-100.00%) on 31 December 2023. PCSA annual CFI is now -100.28% below its all-time high of $1.00 million, reached on 31 December 2017.PCSA Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFI
-$3200.00
0.00%
30 September 2024
Summary:
Processa Pharmaceuticals quarterly cash flow from investing activities is currently -$3200.00Over the past year, it has dropped by -$400.00 (-14.29%). PCSA quarterly CFI is now -100.32% below its all-time high of $1.00 million, reached on 31 December 2017.PCSA Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFI
-$3200.00
0.00%
30 September 2024
Summary:
Processa Pharmaceuticals TTM cash flow from investing activities is currently -$3200.00Over the past year, it has dropped by -$400.00 (-14.29%). PCSA TTM CFI is now -100.32% below its all-time high of $1.00 million, reached on 31 December 2017.PCSA TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PCSA Cash From Investing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -100.0% | -14.3% | -14.3% |
| 3 y3 years | - | - | - |
| 5 y5 years | +87.4% | - | - |
PCSA Cash From Investing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at low | at low | at low | |||
| 5 y | 5 years | +87.4% | at low | at low | |||
| alltime | all time | -100.3% | +99.2% | -100.3% | +99.3% | -100.3% | +99.1% |
Processa Pharmaceuticals Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$3200.00(<-9900.0%) | -$3200.00(+14.3%) |
| Dec 2023 | -$2800.00(<-9900.0%) | $0.00(-100.0%) | -$2800.00(0.0%) |
| Sept 2023 | - | -$2800.00(<-9900.0%) | -$2800.00(<-9900.0%) |
| Dec 2022 | $0.00(-100.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2022 | - | $0.00(0.0%) | $0.00(-100.0%) |
| Dec 2018 | -$22.30 K(-102.2%) | $0.00(-100.0%) | -$22.30 K(-102.3%) |
| Sept 2018 | - | $475.50 K(-195.9%) | $982.70 K(+93.8%) |
| June 2018 | - | -$496.00 K(>+9900.0%) | $507.20 K(-49.4%) |
| Mar 2018 | - | -$1800.00(-100.2%) | $1.00 M(-0.2%) |
| Dec 2017 | $1.00 M(+5811.8%) | $1.00 M(>+9900.0%) | $1.00 M(>+9900.0%) |
| Sept 2017 | - | $0.00(0.0%) | $0.00(-100.0%) |
| June 2017 | - | $0.00(0.0%) | -$25.00 K(+150.0%) |
| Mar 2017 | - | $0.00(0.0%) | -$10.00 K(-158.8%) |
| Dec 2016 | $17.00 K | $0.00(-100.0%) | $17.00 K(-71.0%) |
| Sept 2016 | - | -$25.00 K(-266.7%) | $58.60 K(-29.9%) |
| June 2016 | - | $15.00 K(-44.4%) | $83.60 K(+21.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2016 | - | $27.00 K(-35.1%) | $68.60 K(+70.6%) |
| Dec 2015 | $40.20 K(-189.5%) | $41.60 K(>+9900.0%) | $40.20 K(-267.5%) |
| Sept 2015 | - | $0.00(0.0%) | -$24.00 K(-29.2%) |
| June 2015 | - | $0.00(-100.0%) | -$33.90 K(-5.6%) |
| Mar 2015 | - | -$1400.00(-93.8%) | -$35.90 K(-20.0%) |
| Dec 2014 | -$44.90 K(+62.1%) | -$22.60 K(+128.3%) | -$44.90 K(+101.3%) |
| Sept 2014 | - | -$9900.00(+395.0%) | -$22.30 K(-31.8%) |
| June 2014 | - | -$2000.00(-80.8%) | -$32.70 K(+2.8%) |
| Mar 2014 | - | -$10.40 K(<-9900.0%) | -$31.80 K(+14.8%) |
| Dec 2013 | -$27.70 K(-91.7%) | $0.00(-100.0%) | -$27.70 K(-34.2%) |
| Sept 2013 | - | -$20.30 K(+1745.5%) | -$42.10 K(-84.2%) |
| June 2013 | - | -$1100.00(-82.5%) | -$266.10 K(-21.9%) |
| Mar 2013 | - | -$6300.00(-56.3%) | -$340.70 K(+1.9%) |
| Dec 2012 | -$334.30 K | -$14.40 K(-94.1%) | -$334.40 K(+4.5%) |
| Sept 2012 | - | -$244.30 K(+222.7%) | -$320.00 K(+322.7%) |
| June 2012 | - | -$75.70 K(<-9900.0%) | -$75.70 K(<-9900.0%) |
| Mar 2012 | - | $0.00 | $0.00 |
FAQ
- What is Processa Pharmaceuticals annual cash flow from investing activities?
- What is the all time high annual CFI for Processa Pharmaceuticals?
- What is Processa Pharmaceuticals annual CFI year-on-year change?
- What is Processa Pharmaceuticals quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Processa Pharmaceuticals?
- What is Processa Pharmaceuticals quarterly CFI year-on-year change?
- What is Processa Pharmaceuticals TTM cash flow from investing activities?
- What is the all time high TTM CFI for Processa Pharmaceuticals?
- What is Processa Pharmaceuticals TTM CFI year-on-year change?
What is Processa Pharmaceuticals annual cash flow from investing activities?
The current annual CFI of PCSA is -$2800.00
What is the all time high annual CFI for Processa Pharmaceuticals?
Processa Pharmaceuticals all-time high annual cash flow from investing activities is $1.00 M
What is Processa Pharmaceuticals annual CFI year-on-year change?
Over the past year, PCSA annual cash flow from investing activities has changed by -$2800.00 (-100.00%)
What is Processa Pharmaceuticals quarterly cash flow from investing activities?
The current quarterly CFI of PCSA is -$3200.00
What is the all time high quarterly CFI for Processa Pharmaceuticals?
Processa Pharmaceuticals all-time high quarterly cash flow from investing activities is $1.00 M
What is Processa Pharmaceuticals quarterly CFI year-on-year change?
Over the past year, PCSA quarterly cash flow from investing activities has changed by -$400.00 (-14.29%)
What is Processa Pharmaceuticals TTM cash flow from investing activities?
The current TTM CFI of PCSA is -$3200.00
What is the all time high TTM CFI for Processa Pharmaceuticals?
Processa Pharmaceuticals all-time high TTM cash flow from investing activities is $1.00 M
What is Processa Pharmaceuticals TTM CFI year-on-year change?
Over the past year, PCSA TTM cash flow from investing activities has changed by -$400.00 (-14.29%)